2 AIM growth stocks to consider buying before it’s too late

The AIM (INDEXFTSE:AXX) index is home to some cracking growth candidates.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Alternative Investment Market, or AIM, has more flexible regulations than the main London stock market and can provide advantages to startups and other smaller companies in their early days. Here are two that have just reported, and I like the look of them.

A cracking 10 years

Accesso Technology (LSE: ACSO), formerly known as Lo-Q, does ticketing and virtual queueing systems for amusement parks, water parks and other attractions.

And it’s been very profitable for Accesso shareholders, who have seen their shares soar from around 30p a decade ago to 1,570p today. But is there any more growth to come? Reading Tuesday’s full-year results, I’d say there is.

For 2016 we saw pre-tax profit rise by 40.3% to £10.1m, with operational cash generation up 26.5% to £18.6m (and a healthy 97.4% cash conversion ratio). Adjusted EPS put on 25.7% to 51.48p, and net debt was slashed from £9.4m to £3.4m.

Executive chairman Tom Burnet told us that “2016 has been the year in which I believe Accesso has achieved meaningful scale.” He also spoke of “a significant global opportunity in the medium term,” and that’s what I see as key to Accesso’s future growth now as it turns from a ‘blue sky’ pipsqueak into a more mature global business — but we could be entering something of a two-sided phase now.

What concerns me a little is that when a growth darling starts getting towards maturity and its initial rate of earnings appreciation starts to slow, we can suddenly be facing a forward P/E ratio that’s a little high without the EPS growth to support it in the short term, and that can lead some early investors to jump ship. At today’s share price levels, forecast P/E multiples stand at 35 and 30 for the next two years, which is perhaps discouraging.

I reckon we could be in for a volatile year for Accesso investors with slowing overall share price growth, but I see the company as still being near the start of serious profitability and a good long-term buy.

Pharma prospects

There’s no ambiguity about the growth status of Sinclair Pharma (LSE: SPH), as it’s still in a net-investment and loss-making ‘jam tomorrow’ phase — but that should be coming to an end pretty soon.

Results for 2016 showed a 51% rise in sales to £37.8m, with gross profit up 56% to £26.7m and with a gross margin improving from 68.3% to 70.7%. And the firm’s adjusted EBITDA loss is coming down, from £8m in 2015 to £61.m last year.

Sinclair sold off its non-aesthetics business in 2015 for £132m to become, in its own words, “a fast growth high margin pure-play aesthetics business,” and that looks to be paying off. Chief executive Chris Spooner told us that the board “expects Sinclair to be adjusted EBITDA positive in 2017.”

Analysts seem to be in agreement and are forecasting positive earnings per share by 2018, which would put the 35p shares on a P/E of around 27 — that’s pretty meaningless for a year in which a loss turns into profit, and it wouldn’t take much growth beyond that to drop the P/E to something irresistibly low.

The share price has been erratic over the past year, and I expect more of the same as we’re going through a stage in which it’s hard to assign any meaningful short-term valuation. But I’m optimistic for the longer term.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »